Some 70 cases of Zika virus were identified in India’s Kerala State over the course of July – what represents the first cases to be reported in the southern Indian state, said WHO on Thursday. WHO provided no explanation as to why the report was first published months after the outbreak was initially identified. Subsequently, […] Continue reading ->
Brazil’s official death toll from COVID-19 reached 600,000 late Friday, the second-highest in the world after the US – and a leading epidemiologist blames the Bolsonaro administration for deliberately spreading the virus to achieve “herd immunity”. “Brazil’s federal government put in place a deliberate policy of exposing the population to the pandemic,” according to Cesar […] Continue reading ->
Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting.  There has been a “subtle shifting in the direction of […] Continue reading ->
Two jabs of the Pfizer-BioNTech vaccine are 90% effective against COVID-19 hospitalizations for all variants including Delta, for at least 6 months, confirmed a new study published by The Lancet. The study, conducted by Kaiser Permanete and Pfizer, found that while effectiveness against all SARS-CoV-2 infections declined over the study period, effectiveness against hospitalizations remains […] Continue reading ->
Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading ->